Kimberley Mauroo
Ablynx (Belgium)(BE)ADx NeuroSciences
Publications by Year
Research Areas
Alzheimer's disease research and treatments, Dementia and Cognitive Impairment Research, Parkinson's Disease Mechanisms and Treatments, Amyloidosis: Diagnosis, Treatment, Outcomes, Computational Drug Discovery Methods
Most-Cited Works
- → Combination of plasma amyloid beta(1-42/1-40) and glial fibrillary acidic protein strongly associates with cerebral amyloid pathology(2020)266 cited
- → Comparison of ELISA- and SIMOA-based quantification of plasma Aβ ratios for early detection of cerebral amyloidosis(2020)96 cited
- → Optimized Standard Operating Procedures for the Analysis of Cerebrospinal Fluid Aβ42 and the Ratios of Aβ Isoforms Using Low Protein Binding Tubes(2016)79 cited
- → The global Alzheimer's Association round robin study on plasma amyloid β methods(2021)35 cited
- → Plasma p‐tau181/Aβ 1‐42 ratio predicts Aβ‐PET status and correlates with CSF‐p‐tau181/Aβ 1‐42 and future cognitive decline(2022)28 cited
- → Recommendations for cerebrospinal fluid collection for the analysis by ELISA of neurogranin trunc P75, α-synuclein, and total tau in combination with Aβ(1–42)/Aβ(1–40)(2017)23 cited
- → P3‐089: Measurement of ß‐amyloid isoforms (1‐38, 1‐40, 1‐42) in plasma by new sensitive and accurate elisas(2015)3 cited
- → Plasma p-tau181/Aβ 1-42 ratio predicts Aβ-PET status and correlates with CSF-p-tau181/Aβ 1-42 and future cognitive decline(2022)1 cited
- → Development and analytical characterization of novel tau Simoa assays targeting full‐length tau in CSF and mid‐tau in CSF and plasma(2021)1 cited
- → Comparison of two analytical platforms for blood‐based surrogate biomarkers of amyloid pathology(2020)1 cited